β Home
βΉοΈ Info
π§Ύ Overview π Core Facts π₯ Video Insights β Ratings π§βπΌ Executives π¬ My Commentsπ‘ Analytics
π’ Company Q&A π οΈ Industry Q&A π Competitors π Stock Swings β‘ SWOT ποΈ PEST π Porter's Five Forces β¨ Score Positive β οΈ Risks π§© Segmentationπ§ Tools
β Due DiligenceFinancial Growth
Pay attention and research significant changes from year to year values. [ ! ]
Fixed Column | Revenue Growth | Gross Profit Growth | EBIT Growth | Operating Income Growth | Net Income Growth | EPS Growth | EPS Diluted Growth | Weighted Average Shares Growth | Weighted Average Shares Diluted Growth | Dividends per Share Growth | Operating Cash Flow Growth | Free Cash Flow Growth | Ten Y Revenue Growth Per Share | Five Y Revenue Growth Per Share | Three Y Revenue Growth Per Share | Ten Y Operating CF Growth Per Share | Five Y Operating CF Growth Per Share | Three Y Operating CF Growth Per Share | Ten Y Net Income Growth Per Share | Five Y Net Income Growth Per Share | Three Y Net Income Growth Per Share | Ten Y Shareholders Equity Growth Per Share | Five Y Shareholders Equity Growth Per Share | Three Y Shareholders Equity Growth Per Share | Ten Y Dividend per Share Growth Per Share | Five Y Dividend per Share Growth Per Share | Three Y Dividend per Share Growth Per Share | Receivables Growth | Inventory Growth | Asset Growth | Book Value per Share Growth | Debt Growth | R&D Expense Growth | SGA Expenses Growth |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-12 | 0.1084 | 0.1376 | 0.4887 | 0.4887 | -0.1958 | -0.165 | -0.1732 | -0.0372 | -0.0272 | 0.0914 | 0.2186 | 0.1794 | 0.17 | 0.2173 | 0.097 | 0.5382 | 0.4815 | 0.3112 | 0.419 | 0.9141 | -0.4424 | -0.2448 | -0.0903 | -0.2698 | 0.3583 | 0.3144 | 0.1605 | 0.1741 | -0.0321 | 0.023 | -0.0196 | 0.1863 | -0.1186 | 0.0061 |
2023-12 | -0.0997 | -0.0592 | 0.0621 | 0.0621 | 1.1351 | 1.2413 | 1.2397 | -0.0478 | -0.0477 | 0.0151 | 0.0155 | 0.0121 | -0.0677 | -0.02 | 0.0252 | 0.2899 | 0.1311 | 0.1613 | 0.9023 | 0.3148 | 1.017 | -0.2621 | -0.3371 | -0.0959 | 0.3979 | 0.1629 | 0.1384 | -0.0908 | -0.1758 | -0.149 | -0.1737 | -0.0577 | 0.1375 | -0.1237 |
2022-12 | -0.0198 | -0.018 | -0.6587 | -0.6587 | -0.7104 | -0.7021 | -0.7017 | -0.0273 | -0.0278 | 0.0474 | -0.0554 | -0.0442 | -0.0017 | 0.1118 | 0.1182 | 0.1119 | 0.2131 | 0.0973 | -0.1888 | -0.0288 | 0.022 | -0.0478 | -0.1394 | 0.1234 | 0.3799 | 0.2429 | 0.1863 | 0.0122 | 0.0763 | -0.1088 | -0.0991 | -0.1006 | 0.0477 | -0.0425 |
2021-12 | 0.0597 | 0.0642 | 1.6544 | 1.6544 | 1.9758 | 2.0254 | 2.0198 | -0.0151 | -0.0156 | 0.0707 | 0.1041 | 0.0935 | -0.054 | 0.1341 | 0.0284 | 0.1187 | 0.3926 | 0.0919 | 1.7997 | 2.7948 | 0.9696 | 0.0913 | -0.0413 | -0.11 | 0.4578 | 0.2066 | 0.0937 | -0.027 | -0.0652 | -0.0019 | 0.2152 | -0.1828 | 0.0623 | 0.0485 |
2020-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2019-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2018-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2017-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2016-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2015-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |
2014-12 | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** | **** |

π Explore more financial growth data for Novartis!
Sign up for free or log inβ Download "The Checklist Value Investor β A Smarter Way to Pick Stocks" β totally free!